您要查找的是不是:
- The 3-year overall survival (OS) and disease free survival ( DFS) was 66. 3% and 59. 5% , respectively. 3年總生存率和無病生存率分別為66.;3%25和59
- The 5 -year overall survival (OS) and disease free survival (DFS) were 89% and 73%,respectively. 全組5年總生存率和無病生存率分別為89%25和73%25。
- Univariate analysis showed that patients with low expression of VEGF and MVD had longer disease free survival (DFS) and overall suvival(OS). 單因素預後分析顯示,VEGF及MVD低表達者無病生存期(DFS)及總生存期(OS)長於高表達者。
- The overall 5 year survival rate (OS), disease free survival rate (DFS), distant metastasis free rate(DMF)and local regional free rate (LRF) were 57.1%, 52.9%, 61.0% and 83.3%, respectively. 5年總生存率 (OS)為 5 7.;1%25;5年無瘤生存率 (DFS)為 5 2
- Methods HD-AraC based protocols were used as early and regular intensification regimens to treat childhood AML,and the long-term disease free survival(DFS) rate was calculate with Kaplan-Merier method. 方法以HD-AraC為主的聯合方案作為兒童AML長期化療中的早期和定期強化治療,採用Kaplan-Merier法統計長期無病生存(DFS)率。
- The median disease free survival (DFS) in 144 CR patients whose survival time could be analyzed was 9.6 months. The probability of survival was 21.6% at 3 year and 12.9% at 5 year. 144例可分析生存期的CR患者中位無病生存 (DFS) 9.;6個月;3年實際DFS率為 2 1
- The five-year survival rate (SR),disease free survival rate (DFSR) were 65 6% and 54 5%,respectively. 總的5年生存率、無瘤生存率分別為65.;6%25和54
- The disease free survive (DFS) of 41% (7/17), and of 29% (5/17) was achieved by 3 and 5 years respectively, with 1 case of more than 71 months, 2 cases of more than 96 months, and even 130 and 164 months in other 2 cases. 無病生存 (DFS) 3年者為 41%25 (7/ 17) ; 5年者為 2 9%25 (5 / 17) ,其中 1例超過 71個月 ,2例超過 96個月 ,另 2例分別達130和 16 4個月。
- Patients with poor prognosis had a shorter progression period and shorter disease free survival period. They needed more chemotherapy treatment, and maintenance treatment. 未得到良好治療的病人疾病發展更迅速,生存機會更小。他們需要更多的化學治療和維持治療。
- The overall 5 ,10 year accumulated survival rates (ASR) were 85.1% and 73.2%. The 5 ,10 year disease free survival rates (DFSR) were 68.0% and 63.6% , respectively. 全組 5、10年總生存率分別為 85 .;1%25和 73
- Results In the 74 patients in treatment group, 4 relapsed, 8 metastasized, and 1 patient died;the median disease free survival time (mDFS) for these 13 cases were 6.1 years. 結果中藥組74例中,複發4例,轉移8例,死亡1例,此13例患者的中位無病生存期6.;1年;
- Moreover, patients with higher blood vessels positive area or higher MVD had lower disease free survival rate (DFSR) or overall survival rate (OSR) than those with lower blood vessels positive area or lower MVD. 高血管陽性反應總面積組及高MVD組總生存率(OSR)和無瘤生存率(DFSR)低於低血管陽性反應總面積組和低MVD組(P<0.;005)。
- disease free survival(DFS) 無瘤生存率
- Keywords Leukemia;myelocytic;acute;Child;Clinical protocols;Disease free survival; 關鍵詞白血病;粒細胞;急性;兒童;臨床方案;無病生存;
- Keywords Autologous hematopoietic stem cell transplantation;Hematological malignancies;Overall survival;Disease free survival; 自體造血幹細胞移植;惡性血液病;總生存率;無病生存率;
- The ratio of CR and the time of disease free surival (DFS) with the MDR 1 +/CD 34 + phenotgpe was significantly less than those of the MDR 1 -/CD 34 - phenotype. MDR1 + / CD34+表型細胞較 MDR1 - / CD34-表型細胞緩解率、生存期、緩解期顯著縮短。
- The over-all 3-and 5-year disease free actuarial survival rates were 42% and 33%. 5年生存率為40%25和33%25。
- The first generation comes from disease free nuclear seed. 第一代來自核病免費種子。
- The preliminary result suggested that AHSCT could prolong the disease - free survival for AL, HD and ALC. 初步結果提示AHSCT能延長AL、HD和ALC患者的無病存活期。
- The oncological clearance, the complication rate, the disease free interval and survival were comparable in the two groups. 兩組的腫瘤清除情況、併發症發生率、無瘤間期和生存率無明顯差別。